UC Riverside-led study shows how variations in SARS-CoV-2 host gene expression can be linked to variations in COVID-19 susceptibility and symptom severity
Treatment with a peptide that mimics the naturally occurring protein GIV prevents immune overreaction and supports a mechanism critical for survival in mouse models of sepsis and colitis, according to a UC San Diego study.
The annual UC Riverside School of Medicine Faculty and Student Awards Banquet for 2019-20 was held online via Zoom on Wednesday, Oct. 14, 2020. The event, usually held with a celebratory banquet, was delayed due to the COVID-19 pandemic and eventually converted into an online event when it became clear…
Diverse teams across University of California San Diego, with collaborators elsewhere, have received two 5-year grants totaling $14.3 million from the National Institutes of Health (NIH) Common Fund to continue their work as a 4D Nucleome Research Hub and Center.
Two research teams at UC San Diego School of Medicine sought to understand sedentary lifestyles, with one study finding that even light physical activity, including just standing, can benefit health, and the other that Americans are sitting too much.
The National Heart, Lung, and Blood Institute (NHLBI) and the National Institute on Minority Health and Health Disparities (NIMHD) have awarded a total of $520,000 in funding to the Center for Health Disparities Research at the University of California, Riverside (HDR@UCR) as part of a statewide initiative to address health…
UC San Diego School of Medicine researchers report that older adults are increasingly using cannabis to treat a variety of common health conditions, including pain, sleep disturbances and psychiatric conditions like anxiety and depression.
